Apolipoprotein E*3-Leiden allele results from a partial gene duplication in exon 4
- PMID: 2597162
- DOI: 10.1016/s0006-291x(89)80044-0
Apolipoprotein E*3-Leiden allele results from a partial gene duplication in exon 4
Abstract
The apolipoprotein E3-Leiden variant has been shown to be associated with familial dysbetalipoproteinemia (FD) in a dominant manner (Havekes et al., Hum Genet 1986;73:157-163). Applying the polymerase chain reaction technique, we have cloned and sequenced relevant parts of both APOE alleles of the original proband. In exon 4 of the E*3-Leiden allele a partial gene duplication encompassing 21 nucleotides was found, leading to a tandem repeat of the codons 120-126 or 121-127. Using an E3-Leiden mutation specific oligonucleotide probe, the same mutation was found in two additional independently ascertained FD patients with an E3E3 phenotype based on isoelectric focusing. The E*3-Leiden mutation will be useful in the elucidation of the etiology of dominantly inherited forms of FD.
Similar articles
-
Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.J Clin Invest. 1994 Sep;94(3):1252-62. doi: 10.1172/JCI117443. J Clin Invest. 1994. PMID: 8083367 Free PMC article.
-
Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree.J Clin Invest. 1991 Aug;88(2):643-55. doi: 10.1172/JCI115349. J Clin Invest. 1991. PMID: 1864973 Free PMC article.
-
Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.Hum Genet. 1986 Jun;73(2):157-63. doi: 10.1007/BF00291607. Hum Genet. 1986. PMID: 3721502
-
Familial dysbetalipoproteinemia: a genetically heterogenous disease caused by mutations of the ligand apolipoprotein E.J Invest Dermatol. 1992 Jun;98(6 Suppl):57S-60S. doi: 10.1111/1523-1747.ep12462212. J Invest Dermatol. 1992. PMID: 1588125 Review.
-
Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.Hum Mutat. 1994;4(3):178-94. doi: 10.1002/humu.1380040303. Hum Mutat. 1994. PMID: 7833947 Review.
Cited by
-
Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features.J Atheroscler Thromb. 2025 Mar 1;32(3):281-303. doi: 10.5551/jat.65393. Epub 2025 Jan 8. J Atheroscler Thromb. 2025. PMID: 39779225 Free PMC article. Review.
-
Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.J Clin Invest. 1994 Sep;94(3):1252-62. doi: 10.1172/JCI117443. J Clin Invest. 1994. PMID: 8083367 Free PMC article.
-
Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree.J Clin Invest. 1991 Aug;88(2):643-55. doi: 10.1172/JCI115349. J Clin Invest. 1991. PMID: 1864973 Free PMC article.
-
Dominant expression of type III hyperlipoproteinemia. Pathophysiological insights derived from the structural and kinetic characteristics of ApoE-1 (Lys146-->Glu).J Clin Invest. 1995 Aug;96(2):1100-7. doi: 10.1172/JCI118096. J Clin Invest. 1995. PMID: 7635945 Free PMC article.
-
Atherosclerosis: an overview of mouse models and a detailed methodology to quantify lesions in the aortic root.Vasc Biol. 2024 Apr 4;6(1):e230017. doi: 10.1530/VB-23-0017. Print 2024 Jan 1. Vasc Biol. 2024. PMID: 38428154 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous